{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:07:23Z","timestamp":1790629643385,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"BTG International, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s13181-019-00733-y","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:28:56Z","timestamp":1567535336000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recovery from Copperhead Snake Envenomation: Role of Age, Sex, Bite Location, Severity, and Treatment"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-1451","authenticated-orcid":false,"given":"Eric J.","family":"Lavonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy I.","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Rutherfoord","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Toschlog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P.","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adit A.","family":"Ginde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Gerardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"733_CR1","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/003335490712200608","volume":"122","author":"ME O'Neil","year":"2007","unstructured":"O'Neil ME, Mack KA, Gilchrist J. Epidemiology of non-canine bite and sting injuries treated in U.S. emergency departments, 2001-2004. Pub Health Rep. 2007;122:764\u201375.","journal-title":"Pub Health Rep"},{"key":"733_CR2","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1080\/15563650.2017.1388087","volume":"55","author":"DD Gummin","year":"2017","unstructured":"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 34th annual report. Clin Toxicol. 2017;55:1072\u2013252.","journal-title":"Clin Toxicol"},{"key":"733_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0196-0644(97)70107-0","volume":"30","author":"RC Dart","year":"1997","unstructured":"Dart RC, Seifert SA, Carroll L, Clark RF, Hall E, Boyer-Hassen LV, et al. Affinity-purified, mixed monospecific crotalid ovine fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997;30:33\u20139.","journal-title":"Ann Emerg Med"},{"key":"733_CR4","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1001\/archinte.161.16.2030","volume":"161","author":"RC Dart","year":"2001","unstructured":"Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, et al. A randomized multicenter trial of Crotalinae polyvalent immune fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161:2030\u20136.","journal-title":"Arch Intern Med"},{"key":"733_CR5","unstructured":"Epstein JS. Approval Letter \u2013 CroFab. US Food and Drug Administration, October 2, 2000. Available at: \nhttps:\/\/www.fda.gov:80\/FDAgov\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/FractionatedPlasmaProducts\/ucm117586.htm\n\n. Accessed 16 Nov 2018."},{"key":"733_CR6","doi-asserted-by":"crossref","unstructured":"Seifert SA, Boyer LV, Benson BE, Rogers JJ. AAPCC database characterization of native US venomous snake exposures, 2001 - 2005. Clin Toxicol (Phila). 2009;47(4):327-335.","DOI":"10.1080\/15563650902870277"},{"key":"733_CR7","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1016\/j.annemergmed.2008.06.354","volume":"52","author":"EJ Lavonas","year":"2008","unstructured":"Lavonas EJ, Kerns WP, Gerardo CJ, Richardson W, Whitlow KS, Berkoff DJ. Long-term limb function outcomes after copperhead snakebite. Ann Emerg Med. 2008;52:S141\u20132.","journal-title":"Ann Emerg Med"},{"key":"733_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.annemergmed.2003.08.009","volume":"43","author":"EJ Lavonas","year":"2004","unstructured":"Lavonas EJ, Gerardo CJ, O\u2019Malley GO, Arnold TC, Bush SP, Banner W, et al. Initial experience with crotaline fab antivenom in the treatment of copperhead (Agkistrodon contortrix) snakebite. Ann Emerg Med. 2004;43:200\u20136.","journal-title":"Ann Emerg Med"},{"key":"733_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.annemergmed.2010.06.550","volume":"57","author":"EJ Lavonas","year":"2011","unstructured":"Lavonas EJ, Kokko J, Schaeffer TH, Mlynarchek SL, Bogdan GM, Dart RC. Short-term outcomes following fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2011;57:128\u201337.","journal-title":"Ann Emerg Med"},{"key":"733_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1553-2712.2010.00958.x","volume":"18","author":"S Yin","year":"2011","unstructured":"Yin S, Kokko J, Lavonas E, Mlynarchek S, Bogdan G, Schaeffer T. Factors associated with difficulty achieving initial control with Crotalidae polyvalent immune fab antivenom in snakebite patients. Acad Emerg Med. 2011;18:46\u201352.","journal-title":"Acad Emerg Med"},{"key":"733_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/15563650.2016.1250275","volume":"55","author":"CJ Gerardo","year":"2017","unstructured":"Gerardo CJ, Vissoci JR, Brown MW, Bush SP. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')2 versus fab antivenom trial. Clin Toxicol. 2017;55:109\u201314.","journal-title":"Clin Toxicol"},{"key":"733_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1553-2712.2011.01276.x","volume":"19","author":"TH Schaeffer","year":"2012","unstructured":"Schaeffer TH, Khatri V, Zolot L, Lavonas EJ. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune fab antivenom - a meta-analysis. Acad Emerg Med. 2012;19:121\u201331.","journal-title":"Acad Emerg Med"},{"key":"733_CR13","first-page":"309","volume":"13","author":"KC Kleinschmidt","year":"2018","unstructured":"Kleinschmidt KC, Ruha A-M, Campleman S, Brent J, Wax P, on behalf of the ToxIC North American Snakebite Registry Group. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry. Clin Toxicol. 2018;13:309\u201320.","journal-title":"Clin Toxicol"},{"key":"733_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/15563650.2018.1504956","volume":"57","author":"M Khobrani","year":"2018","unstructured":"Khobrani M, Huckleberry Y, Boesen KJ, Aljabri A, Alharthi M, Patanwala AE. Incidence of allergic reactions to Crotalidae polyvalent immune fab. Clin Toxicol. 2018;57:164\u20137. \nhttps:\/\/doi.org\/10.1080\/15563650.2018.1504956\n\n.","journal-title":"Clin Toxicol"},{"issue":"12","key":"733_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.14423\/SMJ.0000000000000902","volume":"111","author":"Michael E. Mullins","year":"2018","unstructured":"Mullins ME, Gerardo CJ, Bush SP, et al. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial. South Med J. 2018. \nhttps:\/\/doi.org\/10.14423\/SMJ.0000000000000902\n\n.","journal-title":"Southern Medical Journal"},{"key":"733_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.annemergmed.2003.11.013","volume":"43","author":"EM Caravati","year":"2004","unstructured":"Caravati EM. Copperhead bites and Crotalidae polyvalent immune fab (ovine): routine use requires evidence of improved outcomes. Ann Emerg Med. 2004;43:207\u20138.","journal-title":"Ann Emerg Med"},{"key":"733_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.annemergmed.2017.04.034","volume":"70","author":"CJ Gerardo","year":"2017","unstructured":"Gerardo CJ, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, et al. The efficacy of fab antivenom versus placebo plus optional rescue therapy on recovery from copperhead snake envenomation: a randomized, double-blind, placebo-controlled clinical trial. Ann Emerg Med. 2017;70:233\u201344.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"733_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/15563650.2018.1491982","volume":"57","author":"Victoria E. Anderson","year":"2018","unstructured":"Anderson VE, Gerardo CJ, Rapp-Olsson M, Bush SP, Mullins ME, Greene S, Toschlog EA, Quackenbush E, Rose SR, Schwartz RB, Charlton NP, Lewis B, Kleinschmidt KC, Sharma K, Lavonas EJ. Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients. \u00a0Clin Toxicol (Phila). 2019; 57(1):25-30.","journal-title":"Clinical Toxicology"},{"key":"733_CR19","unstructured":"Freiermuth CE, Lavonas EJ, Anderson VE, Kleinschmidt KC, Sharma K, Rapp-Olsson M, et al. Antivenom treatment is associated with fewer patients using opioids after copperhead envenomation. Clin Toxicol. 2019;29(57):25-30."},{"key":"733_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3138\/ptc.47.4.258","volume":"47","author":"P Stratford","year":"1995","unstructured":"Stratford P. Assessing disability and change on individual patients: a report of a patient specific measure. Physiother Can. 1995;47:258\u201363.","journal-title":"Physiother Can"},{"key":"733_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2519\/jospt.2012.3953","volume":"42","author":"C Hefford","year":"2012","unstructured":"Hefford C, Abbott JH, Arnold R, Baxter GD. The patient-specific functional scale: validity, reliability, and responsiveness in patients with upper extremity musculoskeletal problems. J Orthop Sports Phys Ther. 2012;42:56\u201365.","journal-title":"J Orthop Sports Phys Ther."},{"key":"733_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2519\/jospt.2012.3727","volume":"42","author":"KK Horn","year":"2012","unstructured":"Horn KK, Jennings S, Richardson G, Vliet DV, Hefford C, Abbott JH. The patient-specific functional scale: psychometrics, clinimetrics, and application as a clinical outcome measure. J Orthop Sports Phys Ther. 2012;42:30\u201342.","journal-title":"J Orthop Sports Phys Ther"},{"key":"733_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2519\/jospt.1998.27.5.331","volume":"27","author":"MD Westaway","year":"1998","unstructured":"Westaway MD, Stratford PW, Binkley JM. The patient-specific functional scale: validation of its use in persons with neck dysfunction. J Orthop Sports Phys Ther. 1998;27:331\u20138.","journal-title":"J Orthop Sports Phys Ther"},{"key":"733_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/09638288.2015.1044623","volume":"38","author":"S Mannberg B\u00e4ckman","year":"2016","unstructured":"Mannberg B\u00e4ckman S, Str\u00e5t S, Susanne Ahlstr\u00f6m S, Brodin N. Validity and sensitivity to change of the patient specific functional scale used during rehabilitation following proximal humeral fracture. Disabil Rehabil. 2016;38:487\u201392.","journal-title":"Disabil Rehabil"},{"key":"733_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2519\/jospt.2014.5133","volume":"44","author":"MLS Koehorst","year":"2014","unstructured":"Koehorst MLS, van Trijffel E, Lindeboom R. Evaluative measurement properties of the patient-specific functional scale for primary shoulder complaints in physical therapy practice. J Orthop Sports Phys Ther. 2014;44:595\u2013603.","journal-title":"J Orthop Sports Phys Ther"},{"key":"733_CR26","first-page":"649","volume":"53","author":"VE Anderson","year":"2015","unstructured":"Anderson VE, Burnham RI, Gillman SM, Daugherty CA, Gerardo CJ, Lavonas EJ. Validation of patient specific functional scale in copperhead snakebite patients. Clin Toxicol. 2015;53:649.","journal-title":"Clin Toxicol"},{"key":"733_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.toxicon.2018.06.033","volume":"150","author":"CJ Gerardo","year":"2018","unstructured":"Gerardo CJ, Vissoci JRN, Anderson VE, Sharma K, Kleinschmidt KC, Mullins ME, et al. The validity, reliability and minimal clinically important difference of the patient specific functional scale in snake envenomation. Toxicon. 2018;150:352\u20136.","journal-title":"Toxicon"},{"issue":"suppl 5","key":"733_CR28","first-page":"157","volume":"97","author":"RG Theophanous","year":"2017","unstructured":"Theophanous RG, Vissoci JRN, Anderson VE, Lavonas EJ, Gerardo CJ. Telephone Administration of the Patient Specific Functional Scale (PSFS): a valid, reliable, and patient-oriented outcome in global snakebite research. Am J Trop Med Hyg. 2017;97(suppl 5):157\u20138.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-019-00733-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:16:10Z","timestamp":1599002170000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-019-00733-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["733"],"URL":"https:\/\/doi.org\/10.1007\/s13181-019-00733-y","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This clinical trial and the subsequent subgroup analysis were funded by BTG International, Inc. In addition, the Denver Health and Hospital Authority (EJL, RJB, JS, and VJA) has research, consulting, and call center agreements with BTG International, Inc., and has completed research arrangements with the manufacturer of a competing antivenom.\u00a0Duke University (CJG) has received research funding from BTG for projects beyond the current trial. Dr. Green has received income from BTG for professional consulting. No other author has received personal funds or has other conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}